Email this article to a friend
Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care
-
* Corresponding author: Peter Bramlage peter.bramlage@mailbox.tu-dresden.de
BMC Cardiovascular Disorders 2008, 8:30 doi:10.1186/1471-2261-8-30